Root Financial Partners
GYRE icon

Root Financial Partners’s Gyre Therapeutics GYRE Stock Holding History

Root Financial Partners’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$51 Buy
+7
New +$47 ﹤0.01% 3719

Other funds holding GYRE

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GoalVest Advisory
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Root Financial Partners's GYRE Position: Q3 2026 in Review

Root Financial Partners opened a new position in Gyre Therapeutics (GYRE) in Q3 2026: 7 shares worth $51. The stake represents ﹤0.01% of the portfolio and ranks #3719 among its holdings.

7 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

  • Root Financial Partners held 7 shares of Gyre Therapeutics worth $51 as of Q3 2026.
  • Gyre Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Gyre Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3719 holding.
  • 7 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.